FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

13 results

depakote
(Divalproex Sodium)
AbbVie Inc.
Usage: Depakote ER is indicated for treating acute manic or mixed episodes of bipolar disorder, complex partial seizures, simple and complex absence seizures, and for migraine prophylaxis. It is not effective for acute migraine treatment. Considerations regarding pregnancy and potential risks are crucial for women of childbearing potential.
divalproex sodium
(Divalproex Sodium)
Aurobindo Pharma Limited
Usage: Divalproex sodium delayed-release tablets are indicated for treating manic episodes in bipolar disorder, as well as for monotherapy and adjunctive therapy in epilepsy (complex partial and absence seizures). They are also used for migraine prophylaxis but not for acute treatment. Not suitable for pregnant women or those planning pregnancy.
divalproex sodium
(divalproex sodium)
Bionpharma Inc.
Usage: Divalproex sodium is indicated for treating manic episodes in bipolar disorder, managing complex partial and absence seizures in epilepsy, and for migraine prophylaxis. Long-term efficacy in mania is not established. Use is contraindicated in pregnant women and those of childbearing potential not on effective contraception due to risks of fetal harm.
phenytoin
(Phenytoin)
Rising Pharma Holdings, Inc.
Usage: Phenytoin chewable tablets are indicated for treating generalized tonic-clonic and complex partial seizures, as well as for preventing and treating seizures during or after neurosurgery.
primidone
(Primidone)
Advagen Pharma Limited
Usage: Primidone is indicated for controlling grand mal, psychomotor, and focal epileptic seizures, either alone or in combination with other anticonvulsants. It is also effective for grand mal seizures that do not respond to other treatments.
sabril
(vigabatrin)
Lundbeck Pharmaceuticals LLC
Usage: SABRIL is indicated as adjunctive therapy for refractory complex partial seizures in patients aged 2 and older who have not responded to other treatments, and as monotherapy for infantile spasms in pediatric patients aged 1 month to 2 years, weighing the potential benefits against the risk of vision loss.
valproate sodium
(VALPROATE SODIUM)
Fresenius Kabi USA, LLC
Usage: Valproate sodium injection is indicated for intravenous treatment of epilepsy, including complex partial seizures, simple and complex absence seizures, and as adjunct therapy for multiple seizure types. It is not recommended for women who are pregnant or of childbearing potential unless other treatments are ineffective.
valproate sodium
(Valproate Sodium)
Hikma Pharmaceuticals USA Inc.
Usage: Valproate Sodium Injection is indicated for intravenous use in patients with epilepsy, specifically for complex partial, simple and complex absence seizures. It serves as both monotherapy and adjunctive therapy. Usage is limited in women of childbearing potential or during pregnancy due to significant risks to fetal development.
valproate sodium
(valproate sodium)
Athenex Pharmaceutical Division, LLC.
Usage: Valproate Sodium Injection is indicated for intravenous use in epilepsy, specifically for complex partial seizures and simple/complex absence seizures, both as monotherapy and adjunctive therapy. It is not recommended for pregnant women or those of childbearing potential without alternative treatment failures due to potential fetal risks.
valproic acid
(valproic acid)
Upsher-Smith Laboratories, LLC
Usage: Valproic acid capsules are indicated for treating epilepsy, specifically as monotherapy and adjunctive therapy for complex partial seizures, simple and complex absence seizures, and multiple seizure types. Use is limited in women of childbearing potential due to risks of fetal harm and congenital malformations.

Medications for Epilepsy Complex Partial

depakote

divalproex sodium

divalproex sodium

phenytoin

primidone

sabril

valproate sodium

valproate sodium

valproate sodium

valproic acid